Effectiveness of Nebulized Tranexamic Acid in Patients with Moderate-to-Massive Hemoptysis at a Tertiary Academic Medical Center
Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2023
DOI: 10.1089/jamp.2022.0038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2023. Verfasst von Afrah Alkazemi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, College of Pharmacy, Kuwait University, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Tranexamic Acid, Antifibrinolytic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Introduction
The management of severe hemoptysis mainly consists of invasive interventional procedures, including angiographic bronchial artery embolization, various endobronchial interventions, and sometimes surgery. However, there are limited effective noninvasive medical therapies available. The objective of this analysis was to evaluate the effectiveness and safety of nebulized tranexamic acid (TXA) administration compared with conventional management in patients with hemoptysis.
Methods
This Institutional Review Board-approved, single-center, retrospective matched cohort study was performed from January 1, 2018 to March 31, 2021. Electronic health record data were used to identify all adult inpatients with hemoptysis (International Classification of Diseases, Tenth Revision, code R04.2). All patients who received ≥1 dose of nebulized TXA were matched with up to five controls based on available severity criteria (hemoptysis severity, need for mechanical ventilation, and sequential organ failure assessment score at the time of hemoptysis diagnosis) with coarsened exact matching. The primary outcome was the need for invasive interventions for the management of hemoptysis. Secondary outcomes included time to hemoptysis resolution, duration of mechanical ventilation, hemoptysis recurrence, and hospital length of stay.
Results
A total of 14 patients were treated with nebulized TXA; they were matched with 58 controls. Patients were 59.7% male, had a median age of 65.5 years, with airway disease (36.1%) being the major etiology of hemoptysis. There was no difference in the number of patients who required an invasive intervention between the TXA (35.7%) versus control group (56.9%), p = 0.344. Additionally, no difference was found in the time to hemoptysis resolution (p = 0.050), duration on mechanical ventilation (p = 0.128), hemoptysis recurrence (p = 1.000), or hospital length of stay (p = 0.139).
Conclusions
In patients with hemoptysis, nebulized TXA may be considered as a noninvasive option for the management of hemoptysis. However, a larger analysis is warranted to determine the impact of nebulized TXA on invasive interventions for management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, College of Pharmacy, Kuwait University, Kuwait City, Kuwait.
- Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Department of Respiratory Therapy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Afrah Alkazemi
Zitieren
APA
Alkazemi, A., Kovacevic, M., Dube, K., Lauffenburger, J. C., Smith, A., Malinowski, S., & Weinhouse, G. L. (2023). Effectiveness of Nebulized Tranexamic Acid in Patients with Moderate-to-Massive Hemoptysis at a Tertiary Academic Medical Center. Journal of Aerosol Medicine and Pulmonary Drug Delivery. https://doi.org/10.1089/jamp.2022.0038
Vancouver
Alkazemi A, Kovacevic M, Dube K, Lauffenburger JC, Smith A, Malinowski S, et al. Effectiveness of Nebulized Tranexamic Acid in Patients with Moderate-to-Massive Hemoptysis at a Tertiary Academic Medical Center. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2023. doi:10.1089/jamp.2022.0038
BibTeX
@article{Alkazemi2023,
author = {Alkazemi, Afrah and Kovacevic, Mary and Dube, Kevin and Lauffenburger, Julie C and Smith, Adam and Malinowski, Stephen and Weinhouse, Gerald L},
title = {Effectiveness of Nebulized Tranexamic Acid in Patients with Moderate-to-Massive Hemoptysis at a Tertiary Academic Medical Center},
journal = {Journal of Aerosol Medicine and Pulmonary Drug Delivery},
year = {2023},
doi = {10.1089/jamp.2022.0038}
}
EUVIMED